Objective To estimate the minimum clinically important improvement (MCII) and patient
acceptable symptom state (PASS) values for 4 generic outcomes in 5 rheumatic diseases and 7 …

Objective The ability to interpret scores from patient‐reported outcome measures at the
individual patient level depends on the availability of valid, clinically meaningful benchmarks of …

Objective. To establish cutoffs for the minimum clinically important improvement (MCII) and
the patient-acceptable symptom state (PASS) for the Bath Ankylosing Spondylitis Disease …

Dual-energy X-ray absorptiometry (DXA) is the gold standard method for measurement of
bone mineral density (BMD). The aims of the current study are to compare the ability of BMD …

Sarcoidosis is a multisystemic inflammatory disease, still of unknown origin, characterized by
epithelioid non-caseating granuloma in all affected organs. Granuloma formation is lead by …

Hypovitaminosis D is increasing worldwide and is associated with low bone mass. The
effects of hypovitaminosis D on bone might be direct or mediated through decreased muscle …

The International Osteoporosis Foundation recommends using a universal database ie the
NHANES database for the diagnosis of osteoporosis. Population-based databases for T-…

Validation of the European Spondylarthropathy Study Group and B. Amor criteria for
spondylarthropathies in Lebanon. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Fibrinolysis was evaluated in 16 women with SLE, who were divided into three groups of
increasing disease severity according to their past history, and in 10 normal subjects. …

The efficacy of cyclosporin in a double blind, placebo controlled trial of four months' duration
has previously been reported by us. To assess the benefit-to-risk of cyclosporin this study …